Online Purchasing Account You are logged on as Guest. Login Register a New Account Shopping cart (Empty)

Myricetin

Chemopreventive agent



ALX-385-012-M010	10 mg	48.00 USD

ALX-385-012-M050	50 mg	220.00 USD
Do you need bulk/larger quantities?

Antioxidant flavonoid. Has antitumor and chemopreventive properties. Anti-inflammatory. Inhibits NF-κB activation.
PIM1 kinase inhibitor IC₅₀=0.78µM.

Product Details

Alternative Name:	3,3',4',5,5',7-Hexahydroxyflavone

Formula:	C₁₅H₁₀O₈

MW:	318.2

CAS:	529-44-2

MI:	14: 6332

RTECS:	LK8646000

Purity:	≥90% (HPLC)

Appearance:	Light yellow-green crystals.

Solubility:	Soluble in alcohol; slightly soluble in water (warm); insoluble in acetic acid.

Shipping:	Ambient Temperature

Long Term Storage:	-20°C

Handling:	Protect from light.

Regulatory Status:	RUO - Research Use Only

Please mouse over

Product Literature References

A comparison of resveratrol and other polyphenolic compounds on Notch activation and endothelial cell activity: B. LaFoya, et al.; PLoS One 14, e0210607 (2019), Abstract; Full Text

Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase: S. Holder, et al.; Mol. Cancer Ther. 6, 163 (2007), Abstract;

Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1: K.W. Lee, et al.; Carcinogenesis 28, 1918 (2007), Abstract;

Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity: J. Lu, et al.; Cancer Res. 66, 4410 (2006), Abstract;

Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade: C.H. Ko, et al.; Biochem. Pharmacol. 69, 913 (2005), Abstract;

Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells: C.H. Ko, et al.; Mol. Cancer Ther. 4, 281 (2005), Abstract;

In vitro cytotoxicity of glyco-S-nitrosothiols. a novel class of nitric oxide donors: H. Babich & H.L. Zuckerbraun; Toxicol. In Vitro 15, 181 (2001), Abstract;

Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells: S. H. Tsai, et al.; J. Cell Biochem. 74, 606 (1999), Abstract;

Biological effects of myricetin: K. C. Ong & H. E. Khoo; Gen. Pharmacol. 29, 121 (1997), (Review), Abstract;

Structure-antioxidant activity relationships of flavonoids and phenolic acids: C.A. Rice-Evans, et al.; Free Radic. Biol. Med. 20, 933 (1996), (Review), Abstract;